Navigation Links
New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
Date:10/28/2013

Columbus, OH (PRWEB) October 28, 2013

Reports of Pradaxa bleeding side effects continue to mount, according to the Pradaxa lawsuit lawyers at Wright & Schulte LLC. As per the Institute for Safe Medicine Practices’ most recent QuarterWatch publication, the U.S. Food & Drug Administration (FDA) received 3,292 reports of Pradaxa side effects in 2012, more than any other drug it monitors. Most of the reports involved cases of Pradaxa bleeding, and more than 582 detailed fatalities among Pradaxa users.
[ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP QuarterWatch, October 17, 2013]

Click here to learn more about Pradaxa Bleeding Lawsuits

According to Wright & Schulte LLC, the bleeding events reported by the ISMP echo allegations made in more than 1,600 Pradaxa lawsuits currently pending in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois. According to court documents, Boehringer Ingelheim is charged with failing to provide adequate warnings about the drug’s alleged dangers, especially the lack of an antidote for Pradaxa bleeding. The first trials in the Pradaxa litigation will get underway in August 2014. (IN RE: Pradaxa Product Liability Litigation, U.S. District Court, Southern District of Illinois, MDL No. 2385)

Wright & Schulte LLC is currently representing plaintiffs in Pradaxa lawsuits, and continues to offer free legal consultations to alleged victims of Pradaxa side effects, including:

  •     Serious internal bleeding
  •     Intercranial brain bleeding
  •     Stomach and intestinal bleeding
  •     Kidneys and other organs bleeding
  •     Irreversible life threatening bleeding events
  •     Stroke
  •     Heart attack
  •     Severe allergic reaction
  •     Death

For more information on filing a Pradaxa lawsuit, or to arrange for a free legal consultation, please visit yourlegalhelp.com.

As the ISMP’s QuarterWatch report points out, the FDA continues to maintain that Pradaxa is as safe as warfarin, a blood thinner that has been used for decades. But while either drug can cause episodes of serious internal bleeding, the administration of vitamin K can quickly bring warfarin bleeding to an end. According to the ISMP, warfarin was only named in 861 FDA adverse event reports in 2012, with 56 deaths. While 18% of Pradaxa adverse events resulted in a death, only 6.5% of warfarin events were fatal.

[ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP QuarterWatch, October 17, 2013]

The ISMP was sharply critical of the FDA’s stance on Pradaxa: “The agency took several additional actions to reassure doctors and patients that growing number of adverse event reports did not signal an important risk,” the group states. “The FDA’s many actions to discount mounting safety concerns about anticoagulant adverse effects remain unexplained.”

Wright & Schulte LLC, which is already representing plaintiffs in Pradaxa lawsuits, shares many of the concerns raised by the ISMP analysis. The firm’s Pradaxa lawyers agree with the steps the ISMP outlined to improve Pradaxa safety, including:

  •     Reassessment of the current one-dose-fits-all strategy to prevent overdoses in vulnerable, older patients.
  •     More intensive monitoring of kidney function.
  •     Better information to alert physicians about managing the risks associated with a blood thinner that lacks an emergency antidote for serious bleeding.

Wright & Schulte LLC continues to offer free legal consultations to alleged victims of Pradaxa bleeding side effects. For more information on filing a Pradaxa bleeding lawsuit, or to arrange for a free legal consultation, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Pradaxa lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11273472.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
2. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
3. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
4. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
5. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
6. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
7. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
9. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
10. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Boehringer Ingelheim’s Application to Expand Approved Uses for Pradaxa
11. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: